New daily oral treatment aims to tame peanut allergy
NCT ID NCT07117669
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new daily oral treatment called ENP-501 for peanut allergy. It involves 68 healthy volunteers and people with a known peanut allergy. The treatment is given under the tongue daily for up to 52 weeks to see if it is safe and helps people tolerate peanut protein without severe symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ENP-501 (a daily oral treatment placed under the tongue)
- What this could lead to
- If successful, this could lead to a daily treatment that allows people with peanut allergy to tolerate small amounts of peanut without a severe reaction.
- What could go wrong
- This is an early phase 1/2 trial with only 68 participants, so safety and effectiveness are not yet proven. The treatment requires daily use and may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEANUT ALLERGY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site 001
RECRUITINGAurora, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A pill that could outsmart food allergies? trial tests remibrutinib
- Peanut allergy cure in sight? trial tests tolerance in teens
- Can a shot tame peanut allergies? small study tests xolair
- Can allergy drugs help kids tolerate peanut and more?
- Peanut allergy patch enters human safety trials
- Could supermarket peanuts and milk cure food allergies? new study investigates.